{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T17:23:19Z","timestamp":1791912199228,"version":"4.3.4"},"reference-count":30,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.jaip.2026.01.003","type":"journal-article","created":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:31:27Z","timestamp":1768350687000},"page":"668-675","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Generalized Bullous Fixed Drug Eruption: A Systematic Review"],"prefix":"10.1016","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-0793-9482","authenticated-orcid":false,"given":"Li Yang","family":"Loo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nerice Heng Wen","family":"Ngiam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rehena","family":"Sultana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1432-5810","authenticated-orcid":false,"given":"Haur Yueh","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2026.01.003_bib1","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1365-2133.1956.tb12766.x","article-title":"Toxic epidermal necrolysis: an eruption resembling scalding of the skin","volume":"68","author":"Lyell","year":"1956","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2026.01.003_bib2","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1001\/archderm.1993.01680220104023","article-title":"Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme","volume":"129","author":"Bastuji-Garin","year":"1993","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaip.2026.01.003_bib3","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.dsi.2013.09.009","article-title":"Epidermal necrolysis (Stevens-Johnson syndrome and toxic epidermal necrolysis): historical considerations","volume":"31","author":"Roujeau","year":"2013","journal-title":"Dermatol Sin"},{"key":"10.1016\/j.jaip.2026.01.003_bib4","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/bjd.12133","article-title":"Prognosis of generalized bullous fixed drug eruption: comparison with Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"168","author":"Lipowicz","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2026.01.003_bib5","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.jaci.2022.08.028","article-title":"Drug allergy: a 2022 practice parameter update","volume":"150","author":"Khan","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2026.01.003_bib6","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1016\/j.jaip.2024.06.047","article-title":"Delayed skin testing for systemic medications: helpful or not?","volume":"12","author":"Barbaud","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2026.01.003_bib7","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.jaip.2026.01.003_bib8","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan\u2014a web and mobile app for systematic reviews","volume":"5","author":"Mourad Ouzzani","year":"2016","journal-title":"Syst Rev"},{"key":"10.1016\/j.jaip.2026.01.003_bib9","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.4187\/respcare.09541372","article-title":"How to read a case report (or teaching case of the month)","volume":"54","author":"Pierson","year":"2009","journal-title":"Respir Care"},{"key":"10.1016\/j.jaip.2026.01.003_bib10","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1016\/j.jaip.2023.02.035","article-title":"Drug reaction with eosinophilia and systemic symptoms: a systematic review","volume":"11","author":"Awad","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2026.01.003_bib11","first-page":"49","article-title":"Generalized bullous fixed drug eruption associated with cetirizine and hydroxyzine demonstrated by patch test","volume":"45","author":"Arslan","year":"2011","journal-title":"Turk Derm"},{"key":"10.1016\/j.jaip.2026.01.003_bib12","doi-asserted-by":"crossref","first-page":"48","DOI":"10.12788\/cutis.1071","article-title":"Distinguishing generalized bullous fixed drug eruption from SJS\/TEN: a retrospective study on clinical and demographic features","volume":"114","author":"Bang","year":"2024","journal-title":"Cutis"},{"key":"10.1016\/j.jaip.2026.01.003_bib13","doi-asserted-by":"crossref","first-page":"34","DOI":"10.4103\/ijd.ijd_726_22","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis: a fresh look at an old foe","volume":"68","author":"Kaimal","year":"2023","journal-title":"Ind J Dermatol"},{"key":"10.1016\/j.jaip.2026.01.003_bib14","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/978-3-319-29785-9_25","article-title":"Adverse medication reactions","volume":"25","author":"Dodiuk-Gad","year":"2017","journal-title":"Clin Basic Immunodermatol"},{"key":"10.1016\/j.jaip.2026.01.003_bib15","doi-asserted-by":"crossref","first-page":"124","DOI":"10.4103\/ds.DS-D-24-00275","article-title":"Fixed drug eruption\u2013a retrospective review of 146 patients in a tertiary hospital in Southern Taiwan","volume":"43","author":"Yeh","year":"2025","journal-title":"Dermatol Sin"},{"key":"10.1016\/j.jaip.2026.01.003_bib16","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/cod.13351","article-title":"Clinical features, culprit drugs, and allergology workup in 41 cases of fixed drug eruption","volume":"81","author":"Ben Fadhel","year":"2019","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.jaip.2026.01.003_bib17","doi-asserted-by":"crossref","first-page":"415","DOI":"10.4168\/aair.2014.6.5.415","article-title":"Clinical features of fixed drug eruption at a tertiary hospital in Korea","volume":"6","author":"Jung","year":"2014","journal-title":"Allergy Asthma Immunol Res"},{"key":"10.1016\/j.jaip.2026.01.003_bib18","first-page":"1289","article-title":"Fixed drug eruptions\u2013the common and novel culprits since 2000","volume":"20","author":"McClatchy","year":"2022","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.jaip.2026.01.003_bib19","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1056\/NEJM199411103311906","article-title":"Severe adverse cutaneous reactions to drugs","volume":"331","author":"Roujeau","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaip.2026.01.003_bib20","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/sj.jid.5701033","article-title":"Stevens\u2013Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study","volume":"128","author":"Mockenhaupt","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaip.2026.01.003_bib21","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/bcp.12239","article-title":"Usage patterns of \u2018over-the-counter\u2019 vs. prescription-strength nonsteroidal anti-inflammatory drugs in France","volume":"77","author":"Duong","year":"2014","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jaip.2026.01.003_bib22","doi-asserted-by":"crossref","first-page":"18","DOI":"10.53378\/352928","article-title":"Profile, patterns of intake and perceived side effects of over-the-counter non-steroidal anti-inflammatory drugs","volume":"2","author":"Masa","year":"2022","journal-title":"IJSTEM"},{"key":"10.1016\/j.jaip.2026.01.003_bib23","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.amjms.2016.08.028","article-title":"Overuse and misperceptions of nonsteroidal anti-inflammatory drugs in the United States","volume":"352","author":"Cryer","year":"2016","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.jaip.2026.01.003_bib24","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.piel.2018.08.004","article-title":"Generalized bullous fixed drug eruption due to metamizole [article in Spanish]","volume":"34","author":"V\u00e1zquez-Osorio","year":"2019","journal-title":"PIEL"},{"key":"10.1016\/j.jaip.2026.01.003_bib25","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1046\/j.1525-1470.2002.00232.x","article-title":"Extensive fixed drug eruption to nimesulide with cross-sensitivity to sulfonamides in a child","volume":"19","author":"Sarkar","year":"2002","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.jaip.2026.01.003_bib26","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s40257-020-00505-3","article-title":"Fixed drug eruptions: an update, emphasizing the potentially lethal generalized bullous fixed drug eruption","volume":"21","author":"Patel","year":"2020","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jaip.2026.01.003_bib27","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.jaip.2023.10.021","article-title":"In situ patch test and repeated open application test for fixed drug eruption: a multicenter study","volume":"12","author":"Traineau","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2026.01.003_bib28","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/s13671-023-00405-9","article-title":"The safety and accuracy of drug patch testing in delayed hypersensitivity reactions","volume":"12","author":"Saff","year":"2023","journal-title":"Curr Dermatol Rep"},{"key":"10.1016\/j.jaip.2026.01.003_bib29","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1111\/jdv.18220","article-title":"Updated S2 K guidelines for the management of bullous pemphigoid initiated by the European Academy of Dermatology and Venereology (EADV)","volume":"36","author":"Borradori","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaip.2026.01.003_bib30","doi-asserted-by":"crossref","DOI":"10.5070\/D3232033968","article-title":"Generalized bullous fixed drug eruption treated with cyclosporine","volume":"23","author":"Malviya","year":"2017","journal-title":"Dermatol Online J"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219826000061?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219826000061?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T11:50:49Z","timestamp":1781265049000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219826000061"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S2213219826000061"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2026.01.003","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Generalized Bullous Fixed Drug Eruption: A Systematic Review","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2026.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}